A phase II, open-label clinical trial on the combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary disease

Overview of attention for article published in The Journal of Physiological Sciences, October 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 10 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 197,150 followers.

A phase II, open-label clinical trial on the combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary disease https://t.co/C2mFw6sQkR

22 Oct 2019

Reply Repost Favourite

RT @HealthyFellow: A Phase II, Open-Label Clinical Trial on the Combination #Therapy w/ Medium-Chain #Triglycerides & #Ghrelin in #Patients…

22 Oct 2019

Reply Repost Favourite

RT @HealthyFellow: A Phase II, Open-Label Clinical Trial on the Combination #Therapy w/ Medium-Chain #Triglycerides & #Ghrelin in #Patients…

22 Oct 2019

Reply Repost Favourite

RT @HealthyFellow: A Phase II, Open-Label Clinical Trial on the Combination #Therapy w/ Medium-Chain #Triglycerides & #Ghrelin in #Patients…

20 Oct 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.